Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

BACKGROUND: The efficacy of direct-acting antivirals (DAAs) depends on the hepatitis C virus (HCV) genotype 4 (GT4) subtype which are used in the treatment of HCV. We aimed to retrospectively investigate the baseline prevalence of HCV NS5A and NS5B polymorphisms and their impact on virological outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Minosse, Claudia, Selleri, Marina, Giombini, Emanuela, Bartolini, Barbara, Capobianchi, Maria Rosaria, Cerilli, Stefano, Loiacono, Laura, Taibi, Chiara, D’Offizi, Gianpiero, McPhee, Fiona, Garbuglia, AnnaRosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223400/
https://www.ncbi.nlm.nih.gov/pubmed/30464554
http://dx.doi.org/10.2147/IDR.S179158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223400/
https://www.ncbi.nlm.nih.gov/pubmed/30464554
http://dx.doi.org/10.2147/IDR.S179158

Ejemplares similares